MR imaging of the wrist in rheumatoid arthritis using gadobenate dimeglumine

Skeletal Radiology

Volumn 30, Issue 1, 2001, Pages 15-24

  Bonel H M ^a   Schneider, P ^a   Seemann, M D ^a   Huegli, R ^a   Srivastav, S ^a   Lodemann, K P ^a   Reister, M ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Diagnostic imaging; Gadobenate dimeglumine; Gd BOPTA; Low field MRI; Magnetic resonance imaging; Rheumatoid arthritis

Indexed keywords

CONTRAST MEDIUM; GADOBENATE DIMEGLUMINE;

ADULT; ARTICLE; BODY WEIGHT; BONE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; IMAGE QUALITY; INFLAMMATION; MALE; PANNUS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIGNAL NOISE RATIO; WRIST DISEASE;

ADULT; ARTHRITIS, RHEUMATOID; CONTRAST MEDIA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; WRIST JOINT;

EID: 0035113269     PISSN: 03642348     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002560000294     Document Type: Article

References (35)

1. Gadolinium-DTPA in rheumatoid arthritis and related diseases: First results with dynamic magnetic resonance imaging
2. Early-stage rheumatoid arthritis: Diagnostic accuracy of MR imaging
3. Magnetic resonance imaging in the assessment of rheumatoid arthritis: A comparison with plain film radiographs
4. Rheumatoid nodules: MR/pathologic correlation
5. Rheumatoid arthritis of the knee; value of gadopentetate dimeglumine-enhanced MR imaging
6. MRI of the knee in rheumatoid arthritis: Perfusion dynamics
7. Rheumatoid arthritis: Evaluation of hypervascular and fibrous pannus with dynamic MR imaging enhanced with Gd-DTPA
8. MR imaging of the knee in acute uptake of gadolinium-DOTA
9. Juvenile rheumatoid arthritis of the knee: MR evaluation with Gd-DOTA
10. Usage of Gadoteridol in the MR-diagnostics of rheumatoid changes in the joint
11. The necessary dosage of contrast media in MR imaging of rheumatologic inflammatory disease: A comparison between 0.2 and 1.5 Tesla MR scanners
12. Names for Gadobenate Dimeglumine
13. Gadolinium chelates with weak binding to serum proteins: A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging
14. Hepatocellular carcinoma: Evaluation with dynamic and static gadobenate dimeglumine-enhanced MR imaging and histopathologic correlation
15. Gadobenate dimeglumine (Gd-BOPTA): An overview
16. Safety, tolerance, biodistribution and MR imaging enhancement of the liver with gadobenate dimeglumine: Results of clinical pharmacologic and pilot imaging studies in non-patient and patient volunteers
17. Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA): Preliminary results of phase II clinical application
18. Multihance in the assessment of intracranial tumors: Results of phase II clinical studies
19. Evaluation of the efficacy of gadobenate dimeglumine in MR imaging of focal liver lesions: A multicenter phase-III clinical study
20. Gadobenate dimeglumine 0.5 M solution for injection (MultiHance) as contrast agent for magnetic resonance imaging of the liver: Mechanistic studies in animals
21. Interim results of phase II clinical testing of gadobenate dimeglumine
22. Safety and pharmacokinetics of gadobenate dimeglumine in subjects with renal impairment
23. Dedicated MR imaging: An emerging technology
24. Cardiac pacemakers and implantable cardioverter defibrillators are unaffected by operation of an extremity MR imaging system
25. Comparison of sequences for depicting bone marrow alterations in osteomyelitis applied on a low-field strength magnetic resonance imaging system
26. MRI of fingers in systemic scleroderma: Initial results with contrast-enhanced studies using a dedicated MRI system
27. Assessing contrast on MR images
28. Gadolinium-enhanced MR imaging of the wrist in rheumatoid arthritis: Value of fat suppression pulse sequences
29. Targeted relaxation enhancement agents for MRI
30. Hepatic transport of the magnetic resonance imaging contrast agent gadobenate dimeglumine in TR-rats
31. Soluble-type hepatobiliary contrast agents for MR imaging
32. Intraarticular diffusion of Gd-DOTA after intravenous injection of the knee: MR evaluation
33. Synovial membrane disorders